{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-097364","form_type":"8-K12B","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2023-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.326666+00:00","generated_at":"2026-06-07T09:48:16.009773+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Silo Pharma reincorporates from Delaware to Nevada, effective December 19, 2023","bullets":["Reincorporation completed via Plan of Conversion approved by stockholders on Dec 4/11, 2023.","Each outstanding share of Delaware common stock converted one-for-one into Nevada common stock.","Options, warrants, and equity plans continue on same terms; no exchange of stock certificates required.","Ticker remains SILO on Nasdaq; business, management, and offices unchanged.","Stockholder rights now governed by Nevada law; differences detailed in Oct 23, 2023 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-097364","json":"https://secwatch.observer/filing/0001213900-23-097364.json","markdown":"https://secwatch.observer/filing/0001213900-23-097364.md","text":"https://secwatch.observer/filing/0001213900-23-097364.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023097364/0001213900-23-097364-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023097364/ea190371-8k12b_silopharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T09:48:16.009773+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}